Half of advanced melanoma patients achieve a 10-year survival with dual drug therapy
Scientific Asia: Experts applaud “remarkable” trial findings for treating a type of skin cancer for which there was previously little hope. A double dose of immunotherapy medications has been proven to prolong survival for over half of patients with advanced melanoma for at least ten years, according to a trial. With the combined treatment, survival…
Scientific Asia